Women should be offered a choice of treatment options for miscarriage, study shows
Women experiencing miscarriage should be offered a choice in the treatment they receive, argues a new study from the University of Warwick that compares all treatment options for the first time
- First-ever comprehensive comparison of all treatment options for miscarriage demonstrates little to no difference in medical effectiveness in resolving an unsuccessful pregnancy between medical and surgical options.
- Various side effects among treatments were highlighted, including increased bleeding, anxiety, long waiting times and long recovery periods, evidence was not consistent
- UK national guidelines recommend natural delivery as first option, which resolves 70% of cases – but side effects are not well evaluated and communicated to women
- All treatment options should be offered to women undergoing first trimester miscarriage, argue University of Warwick and Queen Mary University of London researchers
- Miscarriage affects an estimated 1 in 4 pregnancies
Women experiencing miscarriage should be offered a choice in the treatment they receive, argues a new study from the University of Warwick that compares all treatment options for the first time.
Although national guidelines recommend trying to resolve an unsuccessful pregnancy naturally, the new analysis shows that this is only successful in 70% of cases, and potentially comes with complications that are rarely communicated to patients.
Researchers from the University of Warwick and Queen Mary University of London compared for the first time all treatment options available to women experiencing miscarriage, providing comprehensive evidence that all options are similarly effective. They recommend that doctors offer women a choice of treatment options for miscarriage to enable them to make an informed decision that takes account of potential uncomfortable side effects, long waiting times and extended periods of recovery.
The results of the study, which reviews 46 trials involving over 9,000 women, have been published in the journal Human Reproduction Update.
Miscarriage can be a traumatic experience for both parents, resulting in feelings of loss and grief that in some cases can lead to anxiety and depression that adversely affects a couple’s ability to resume their fertility. Miscarriage is the most common complication of pregnancy and affects an estimated 1 in 4 pregnancies.
The study looked into the treatment options offered to women who experienced spontaneous loss of pregnancy (miscarriage) before 14 weeks gestation, which included conservative treatment. During a miscarriage, the body will aim to resolve the unsuccessful pregnancy naturally but this process can be painful with increased bleeding, increased likelihood of hospital admission, reduced quality of treatment and reduced satisfaction. The study showed that conservative treatment could resolve miscarriage in about 70% of cases.
However, surgery and medical treatment with a tablet had similar effectiveness in treating miscarriage as conservative treatment. The surgical options include electric vacuum aspiration, offered by the majority of hospitals in the NHS, which requires a general anaesthetic and trip to the operating theatre. Manual vacuum aspiration is not a common service in the NHS yet and requires special training by healthcare professionals, but can be performed under local anaesthetic and with less waiting time.
National guidelines from NICE recommend conservative treatment as a first line of treatment before offering medical or surgical treatment if the miscarriage is not resolved within two weeks.
Lead author Dr Bassel Wattar, from Warwick Medical School, said: “Our research has compared all these treatment options and demonstrated that there’s not much difference between taking a medical tablet or going through either types of surgery. Arguably, the manual vacuum treatment results in a better patient experience because women get to go home quicker and get to start their recovery faster. Furthermore, it has cost-saving benefits to the NHS because there’s less use of resources.
“What we have to do is provide women with evidence about the benefits and effectiveness of each treatment option and potential side effects so that they can choose what they feel most comfortable with. Some women are more keen on having a quick surgical intervention so that they can resume their lifestyle immediately, some are very keen to avoid surgery and prefer to go with a tablet, and others want to take a more natural approach.
“While conservative management sounds like a natural treatment, it might come with more side effects than if you compare it to a tablet that can finish the process quicker and faster.”
The researchers argue that the focus of research in the past has been on effectiveness of the treatment and few studies have considered other important factors such as post-treatment stress and side effects.
Dr Wattar adds: “A lot of previous research had not worked with women to understand what factors are of greatest concern to them, specifically the tolerability of each treatment option, time to return to work, satisfaction or pain. These are equally important and need to be reported on in future.
“There is evidence that if we offer all these treatment options to women then their satisfaction with the treatment is likely to be higher and we can provide a more efficient service. For example, if you offer surgery under local anaesthetic, waiting times for theatre will be less, use of equipment will be reduced and return to work for the patient will be faster. The overall bill to society and the health system would also be reduced if we offered all treatment options.”
* ‘Management of first-trimester miscarriage: a systematic review and network meta-analysis’ is published in Human Reproduction Update, doi:10.1093/humupd/dmz002
Notes to editors:
For more information/interviews contact:
Media Relations Manager (Warwick Medical School and Department of Physics) | Press &
Media Relations | University of Warwick
Email: [email protected] | Tel: +44 (0)24 761 50868 | Mob: +44 (0) 7824 540863 |
About Queen Mary University of London
Queen Mary University of London is a world-leading research-intensive university with over 25,000 students representing more than 160 nationalities.
A member of the prestigious Russell Group, we work across the humanities and social sciences, medicine and dentistry, and science and engineering, with inspirational teaching directly informed by our research.
In the most recent exercise that rated research in the UK, we were ranked 5th in the country for the proportion of research outputs that were world-leading or internationally excellent. We offer more than 240 degree programmes and our reputation for excellent teaching was rewarded with a silver in the 2017 Teaching Excellence Framework (TEF) awards.
Queen Mary’s history dates back to 1785, with the foundation of the London Hospital Medical College. Our history also encompasses the establishment of the People’s Palace in 1887, which brought accessible education, culture and recreation to the East End of London. We also have roots in Westfield College, one of the first colleges to provide higher education to women.